Archived Monthly Oncology Tumor Boards: Management of Recurrent/Metastatic Cervical Cancer and Neuroendocrine Carcinoma of the Cervix
The management of cervical cancer specific to histology, stage, and setting has changed tremendously and a review of new/latest data is important and helpful for the practitioners in treatment decision-making. Clinicians can benefit from continued education on comparing treatment options to best manage different histological types of cervical cancer.
Monthly Oncology Tumor Boards: Management of Recurrent/Metastatic Cervical Cancer and Neuroendocrine Carcinoma of the Cervix
The management of cervical cancer specific to histology, stage, and setting has changed tremendously and a review of new/latest data is important and helpful for the practitioners in treatment decision-making. Clinicians can benefit from continued education on comparing treatment options to best manage different histological types of cervical cancer.
Management of Recurrent or Metastatic Cervical Cancer
The systemic therapy section of the NCCN Guidelines for Cervical Cancer has continuously added new therapy options over the past few years to reflect the new approvals. Knowledge in this topic will guide the practitioners in appropriately prioritizing these new treatment options to further improve patient outcomes.
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2024
These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.
NCCN Guidelines® Insights - Cervical Cancer, Version 1.2020
These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to first- and second-line systemic therapy recommendations for patients with recurrent or metastatic disease, and emerging evidence on a new histopathologic classification system for HPV-related endocervical adenocarcinoma.
The Role of Imaging for Staging and Treatment Planning in Gynecologic Malignancies

This information was originally presented at the NCCN 2017 Oncology Fellows Program: New Horizons in Quality Cancer Care™ held on March 26, 2017.

Minimally Invasive Techniques for Treating Gynecologic Malignancies

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

Evolving Treatment Strategies for Cervical Cancer

This information was originally presented at the NCCN 21st Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida, from March 31 – April 2, 2016.

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Cervical Cancer

Join Larissa Lee, MD and Ursula Matulonis, MD from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to cervical cancer.

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Cervical Cancer

Join Larissa Lee, MD and Ursula Matulonis, MD from Dana-Farber Cancer Institute as they present their multidisciplinary expertise on a range of cases pertaining to cervical cancer.

Pages

Subscribe to RSS - Cervical Cancer